Analysts’ Weekly Ratings Updates for MedEquities Realty Trust (MRT)

Share on StockTwits

MedEquities Realty Trust (NYSE: MRT) recently received a number of ratings updates from brokerages and research firms:

  • 1/4/2019 – MedEquities Realty Trust was downgraded by analysts at Raymond James to a “market perform” rating.
  • 1/3/2019 – MedEquities Realty Trust had its “neutral” rating reaffirmed by analysts at B. Riley. They now have a $10.00 price target on the stock, down previously from $10.50.
  • 1/2/2019 – MedEquities Realty Trust was upgraded by analysts at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating.
  • 1/2/2019 – MedEquities Realty Trust was downgraded by analysts at JMP Securities to a “market perform” rating.
  • 1/2/2019 – MedEquities Realty Trust was upgraded by analysts at ValuEngine from a “sell” rating to a “hold” rating.
  • 12/15/2018 – MedEquities Realty Trust was upgraded by analysts at ValuEngine from a “strong sell” rating to a “sell” rating.
  • 11/30/2018 – MedEquities Realty Trust was downgraded by analysts at TheStreet from a “c-” rating to a “d+” rating.
  • 11/23/2018 – MedEquities Realty Trust was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “MedEquities Realty Trust, Inc. owns, develops, operates, leases and disposes healthcare properties and portfolios. It operates primarily in Texas, California, Nevada and South Carolina. MedEquities Realty Trust, Inc. is based in Nashville, Tennessee. “
  • 11/20/2018 – MedEquities Realty Trust had its price target lowered by analysts at Raymond James from $12.00 to $10.00. They now have a “buy” rating on the stock.
  • 11/13/2018 – MedEquities Realty Trust had its price target lowered by analysts at B. Riley from $12.00 to $11.00. They now have a “buy” rating on the stock.
  • 11/12/2018 – MedEquities Realty Trust was upgraded by analysts at Citigroup Inc from a “sell” rating to a “neutral” rating. They now have a $9.00 price target on the stock.

MedEquities Realty Trust stock traded up $0.13 during trading hours on Thursday, hitting $10.62. 73,301 shares of the stock were exchanged, compared to its average volume of 2,473,017. The stock has a market capitalization of $321.49 million, a price-to-earnings ratio of 9.32 and a beta of 0.30. MedEquities Realty Trust Inc has a 12 month low of $6.27 and a 12 month high of $11.85.

MedEquities Realty Trust (NYSE:MRT) last issued its quarterly earnings data on Monday, November 12th. The financial services provider reported ($0.07) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.18 by ($0.25). The firm had revenue of $9.68 million for the quarter, compared to the consensus estimate of $17.72 million. MedEquities Realty Trust had a return on equity of 3.39% and a net margin of 19.98%. As a group, equities analysts expect that MedEquities Realty Trust Inc will post 0.8 EPS for the current fiscal year.

In other MedEquities Realty Trust news, Director Bluemountain Capital Managemen sold 4,617 shares of the company’s stock in a transaction dated Thursday, December 6th. The shares were sold at an average price of $6.67, for a total transaction of $30,795.39. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders have sold 421,464 shares of company stock worth $3,396,223 over the last ninety days. Insiders own 3.00% of the company’s stock.

Several institutional investors and hedge funds have recently added to or reduced their stakes in MRT. Schwab Charles Investment Management Inc. grew its stake in shares of MedEquities Realty Trust by 0.7% during the second quarter. Schwab Charles Investment Management Inc. now owns 764,932 shares of the financial services provider’s stock valued at $8,430,000 after purchasing an additional 5,106 shares during the last quarter. BlackRock Inc. boosted its stake in MedEquities Realty Trust by 5.5% in the second quarter. BlackRock Inc. now owns 1,499,494 shares of the financial services provider’s stock valued at $16,526,000 after acquiring an additional 77,884 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in MedEquities Realty Trust by 23.8% in the second quarter. Dimensional Fund Advisors LP now owns 92,794 shares of the financial services provider’s stock valued at $1,023,000 after acquiring an additional 17,862 shares during the last quarter. Citadel Advisors LLC boosted its stake in MedEquities Realty Trust by 82.0% in the second quarter. Citadel Advisors LLC now owns 29,486 shares of the financial services provider’s stock valued at $325,000 after acquiring an additional 13,284 shares during the last quarter. Finally, Renaissance Technologies LLC boosted its stake in MedEquities Realty Trust by 36.0% in the second quarter. Renaissance Technologies LLC now owns 839,800 shares of the financial services provider’s stock valued at $9,255,000 after acquiring an additional 222,500 shares during the last quarter. 92.04% of the stock is currently owned by institutional investors and hedge funds.

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

Read More: Differences Between Momentum Investing and Long Term Investing

Receive News & Ratings for MedEquities Realty Trust Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply